An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that causes the disease, Mycobacterium tuberculosis, is deadly in part because of ...

Tuberculosis (TB) cases rose 13 per cent in England last year, with increases among both immigrants and people born in the UK ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...

March 24, 2025, was set aside by the World Health Organisation as World Tuberculosis Day to commemorate the day in 1882 when one of the true giants of early medicine, Dr Robert Koch, announced his ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

M4TB, through its participation in ERA4TB – a European Union’s Horizon 2020 research and innovation program – is supporting initial development of a long-acting injectable ...

The first World TB Day was observed in 1982, a full century after Koch’s groundbreaking discovery. Tuberculosis is notable for causing fever, a persistent cough that produces yellowish sputum ...

The number of notified paediatric tuberculosis (TB) cases has increased by 38 per cent in children aged up to 14 years in the ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

The 25% reduction in the price of pretomanid could save Global Drug Facility clients upwards of $3 million a year.

Scripps Research team offers insights that could aid development of phage therapies against Mycobacteria The pathogens which ...